A detailed history of Byrne Asset Management LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Byrne Asset Management LLC holds 390 shares of ZTS stock, worth $46,332. This represents 0.03% of its overall portfolio holdings.

Number of Shares
390
Previous 390 -0.0%
Holding current value
$46,332
Previous $57,000 19.3%
% of portfolio
0.03%
Previous 0.04%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 22, 2025

BUY
$141.13 - $159.19 $12,701 - $14,327
90 Added 30.0%
390 $57,000
Q2 2025

Jul 09, 2025

SELL
$144.41 - $170.3 $18,051 - $21,287
-125 Reduced 29.41%
300 $46,000
Q1 2025

Apr 16, 2025

BUY
$156.48 - $175.67 $66,504 - $74,659
425 New
425 $69,000
Q4 2023

Jan 29, 2024

SELL
$151.44 - $200.09 $605 - $800
-4 Reduced 13.33%
26 $5,000
Q2 2023

Jul 21, 2023

SELL
$160.94 - $186.23 $1,609 - $1,862
-10 Reduced 25.0%
30 $5,000
Q4 2021

Feb 22, 2022

BUY
$193.69 - $247.03 $7,747 - $9,881
40 New
40 $10,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $55.6B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Byrne Asset Management LLC Portfolio

Follow Byrne Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Byrne Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Byrne Asset Management LLC with notifications on news.